Postoperative intraperitoneal (IP) 5'-fluoro-2'-deoxyuridine (FUDR) added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma

Elliot Newman,R.Y. Chang,Milan Potmesil,Bernadine Donahue,Stuart G. Marcus,Spiros P. Hiotis,Syma Iqbal,Theresa Ryan,Howard S. Hochster,Franco M. Muggia

Postoperative intraperitoneal (IP) 5'-fluoro-2'-deoxyuridine (FUDR) added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma

2005

Elliot Newman
R.Y. Chang
Milan Potmesil
Bernadine Donahue
Stuart G. Marcus
Spiros P. Hiotis
Syma Iqbal
Theresa Ryan
Howard S. Hochster
Franco M. Muggia

4163 Background: Locally advanced gastric cancer, AJCC stage IB-IV (M0), is the most common presentation among patients (pts) in the US. Intergroup trial 0116 (NEJM, 2000, 345:925) evaluated the ro...

Keywords:

Gastroenterology
Pathology
Deoxyuridine
Gastroesophageal Junction
Medicine
Internal medicine
Adenocarcinoma
Cancer
locally advanced
ajcc stage
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations